Argus
http://www.argusresearch.com/Argus is an independent equity research firm with approximately 500 leading US companies across more than 60 industries in its coverage universe. The firm employs a simple Buy, Hold, and Sell rating system to reflect its outlook on companies.
View Older Stories View More Recent Stories
-
Second Sight Medical (EYES) Names John T. Blake as Chief Financial Officer
-
Second Sight Appoints John T. Blake Chief Financial Officer
-
Second Sight Medical (EYES) Names Gregg Williams to Board
-
Second Sight Appoints Gregg Williams as Chairman of the Board of Directors
-
Second Sight Medical Products, Inc. to Present at the B. Riley & Co. China Healthcare Investment Partnering Symposium
-
Pre-Open Movers 03/08: (ESRX) (BBRG) (EYES) Higher; (VBLT) (MYO) (MEET) Lower (more...)
-
Second Sight Reports Fourth Quarter and Full Year 2017 Financial Results
-
Second Sight Medical (EYES) Reports Expansion of Medicare Coverage for Argus II Retinal Prosthesis
-
Second Sight Announces Latest Expansion of Medicare Coverage for Argus II Retinal Prosthesis System
-
Second Sight Medical Products, Inc. to Present at the Inaugural LD Micro Virtual Investor Conference on March 7, 2018
-
Second Sight to Discuss Fourth Quarter and Year-End 2017 Financial Results on March 7, 2018 Conference Call
-
Pre-Open Movers 02/16: (SNCR) (MULE) (CALA) Higher; (RIOT) (COHU) (ANET) Lower (more...)
-
Second Sight Medical (EYES) Gains Following Entry into Singapore
-
Second Sight Announces Market Entry into Singapore with First Implant of Argus II Retinal Prosthesis System
-
Second Sight Medical (EYES) Provides Update on Key Performance Metrics
-
Second Sight Announces Record Number of Argus II Retinal Prosthesis Systems Implants and Completes First-in-Human Orion Cortical Implant
-
Second Sight Announces Market Entry into Iran with First Two Implants of Argus II Retinal Prosthesis System
-
Second Sight Medical (EYES) Says OHTAC Recommends Public Funding for its Argus II Retinal Prosthesis System
-
Ontario Health Technology Advisory Committee Recommends Public Funding for Second Sight’s Argus II Retinal Prosthesis System
-
Second Sight Medical (EYES) Announces FDA Expedited Access Pathway Designation for Orion Cortical Visual Prosthesis System
-
Second Sight Receives FDA Expedited Access Pathway Designation for the Orion Cortical Visual Prosthesis System
-
Second Sight Reports Third Quarter 2017 Financial Results
-
Pre-Open Movers 11/02: (ESIO) (NBIX) (EYES) Higher; (PI) (NWL) (W) Lower (more...)
-
Second Sight Medical (EYES) Announces Argus II Final Medicare Hospital Outpatient Payment Rate for 2018
-
Second Sight Receives Full FDA Approval to Begin First Orion Human Clinical Study
-
Second Sight Announces Final Medicare Hospital Outpatient Payment Rate for 2018 for the Argus II Retinal Prosthesis System
-
Second Sight to Discuss Third Quarter 2017 Financial Results on November 2, 2017 Conference Call
-
Second Sight Announces Appointments of Frank Vandeputte as Vice President and General Manager, EMEA and Asia Pacific; Gregoire Cosendai as Vice President, Clinical Affairs
-
Pre-Open Movers 10/17: (SNCR) (EYES) (IMDZ) Higher; (BMI) (IPXL) (HOG) Lower (more...)
-
Second Sight Medical (EYES) Granted Approval in Germany to Commence Study to Implant and Evaluate Argus II
-
Second Sight Receives Approval from Bundesinstitut für Arzneimittel und Medizinprodukte in Germany to Begin Study to Implant and Evaluate Argus II in Better-Sighted Retinitis Pigmentosa Patients
-
Second Sight to Present at the 19th Annual Rodman & Renshaw Global Investment Conference in New York on September 12th
-
Second Sight Medical (EYES) Granted Conditional FDA Approval to Commence First Orion Human Clinical Study
-
Second Sight Receives Conditional FDA Approval to Begin First Orion Human Clinical Study
-
Second Sight Medical (EYES) Tops Q2 EPS by 3c
-
Second Sight Reports Second Quarter 2017 Financial Results
-
Second Sight Medical (EYES) Reports First Implant of Argus II Retinal Prosthesis in Russia
-
Second Sight Announces Market Entry into Russia with First Implant of Argus II Retinal Prosthesis System
-
Second Sight to Discuss Second Quarter 2017 Financial Results on August 1, 2017 Conference Call
-
Second Sight Announces Market Entry into South Korea with Two Implants and Performs Second Implant in Taiwan of Argus II Retinal Prosthesis System
-
Pre-Open Movers 07/03: (OPXA) (EYES) (RATE) Higher; (RICE) (AVAV) (MLCO) Lower (more...)
-
Second Sight Medical (EYES) Gains as Medicare Coverage for Argus II Expands
-
Second Sight Announces Expansion of Medicare Coverage for Argus II Retinal Prosthesis System to 11 Additional States and the District of Columbia
-
Second Sight to Present at 18th Annual B. Riley & Co. Institutional Investor Conference
-
Second Sight Reports First Quarter 2017 Financial Results
-
Second Sight to Discuss First Quarter 2017 Financial Results on May 3, 2017 Conference Call
-
Second Sight Medical (EYES) Gains 25% Pre-Market on Positive Argus II News
-
Second Sight Medical (EYES) Announces Argus II Implanted in First Patient in Asia
-
Second Sight’s Argus II Retinal Prosthesis Implanted in First Patient in Asia
-
Second Sight Announces Dr. Robert Greenberg, Chairman, Inducted as a National Academy of Inventors Fellow

